Steven Jasper
Managing Director, Gilmartin Group
Replay available
Metagenomi Therapeutics, Inc. (MGX) Q3 2025 Earnings Call
Metagenomi Therapeutics, Inc. (NASDAQ: MGX) Q3 2025 earnings conference call, held 2025-11-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Irish
Chief Executive Officer, Metagenomic
Dr. Glenn Pierce
Independent Advisor & Hemophilia Physician-Scientist; Vice President Medical, World Federation of Hemophilia
Alan Brooks
Senior Vice President of Research, Metagenomic
Pamela Webnick
Chief Financial Officer, Metagenomic
Yanen Zhu
Analyst, Wells Fargo Securities
Joseph Thome
Analyst, TD Cowen
Maury Raycroft
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Metagenomi Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.934 Good day and thank you for standing by. Welcome to the MGX-001 00:00:05.036 -- 00:00:07.698 program and business update conference call. 00:00:07.698 -- 00:00:10.761 At this time, all participants are in a listen-only mode. 00:00:10.761 -- 00:00:13.984 Please be advised that today's conference is being recorded. 00:00:13.984 -- 00:00:18.248 After the speaker's presentation, there will be a question and answer session. 00:00:18.248 -- 00:00:22.692 To ask a question, please press star 1-1 on your telephone and wait for your name to 00:00:22.692 -- 00:00:26.615 be announced. To withdraw your question, please press star 1-1 again. 00:00:26.615 -- 00:00:30.288 I would now like to hand the conference over to your speaker today. 00:00:30.288 -- 00:00:35.012 Steven Jasper, Managing Director at Gilmartin Group. 00:00:36.196 -- 00:00:40.563 Ladies and gentlemen, welcome to the Metagenomic Conference Call to discuss the company's 00:00:40.563 -- 00:00:42.405 MGX-001 00:00:42.405 -- 00:00:47.433 program and business updates. Before we begin, please note that this conference call 00:00:47.433 -- 00:00:52.039 will include forward-looking statements made pursuant to the safe harbor provisions of 00:00:52.039 -- 00:00:56.309 the Private Securities Litigation Reform Act of 1995. 00:00:56.309 -- 00:01:01.754 Please refer to our most recent Form 10-K and 10-Q on file with the SEC 00:01:01.754 -- 00:01:06.358 for important risk factors that could cause our actual performance and results to differ 00:01:06.358 -- 00:01:11.723 materially from those expressed or implied in these forward-looking statements. 00:01:11.723 -- 00:01:15.786 Joining us on the call today with prepared remarks are the company's newly appointed 00:01:15.786 -- 00:01:20.951 Chief E...